Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2158 | 2267 | 33.1 | 72% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
903 | 10618 | DIHYDROPYRIMIDINE DEHYDROGENASE//5 FLUOROURACIL//THYMIDINE PHOSPHORYLASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | OXALIPLATIN | Author keyword | 75 | 18% | 16% | 370 |
2 | CAPECITABINE | Author keyword | 63 | 20% | 12% | 282 |
3 | IRINOTECAN | Author keyword | 60 | 17% | 14% | 317 |
4 | ADVANCED COLORECTAL CANCER | Author keyword | 58 | 47% | 4% | 90 |
5 | RALTITREXED | Author keyword | 51 | 49% | 3% | 77 |
6 | LEUCOVORIN | Author keyword | 36 | 24% | 6% | 130 |
7 | UFT | Author keyword | 35 | 35% | 4% | 82 |
8 | METASTATIC COLORECTAL CANCER | Author keyword | 28 | 21% | 5% | 121 |
9 | ADVANCED COLORECTAL CARCINOMA | Author keyword | 18 | 65% | 1% | 17 |
10 | XELOX | Author keyword | 13 | 47% | 1% | 21 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OXALIPLATIN | 75 | 18% | 16% | 370 | Search OXALIPLATIN | Search OXALIPLATIN |
2 | CAPECITABINE | 63 | 20% | 12% | 282 | Search CAPECITABINE | Search CAPECITABINE |
3 | IRINOTECAN | 60 | 17% | 14% | 317 | Search IRINOTECAN | Search IRINOTECAN |
4 | ADVANCED COLORECTAL CANCER | 58 | 47% | 4% | 90 | Search ADVANCED+COLORECTAL+CANCER | Search ADVANCED+COLORECTAL+CANCER |
5 | RALTITREXED | 51 | 49% | 3% | 77 | Search RALTITREXED | Search RALTITREXED |
6 | LEUCOVORIN | 36 | 24% | 6% | 130 | Search LEUCOVORIN | Search LEUCOVORIN |
7 | UFT | 35 | 35% | 4% | 82 | Search UFT | Search UFT |
8 | METASTATIC COLORECTAL CANCER | 28 | 21% | 5% | 121 | Search METASTATIC+COLORECTAL+CANCER | Search METASTATIC+COLORECTAL+CANCER |
9 | ADVANCED COLORECTAL CARCINOMA | 18 | 65% | 1% | 17 | Search ADVANCED+COLORECTAL+CARCINOMA | Search ADVANCED+COLORECTAL+CARCINOMA |
10 | XELOX | 13 | 47% | 1% | 21 | Search XELOX | Search XELOX |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LEUCOVORIN | 128 | 19% | 27% | 623 |
2 | FLUOROURACIL FAILURE | 115 | 49% | 7% | 170 |
3 | FLUOROURACIL PLUS LEUCOVORIN | 115 | 43% | 9% | 205 |
4 | HIGH DOSE LEUCOVORIN | 102 | 36% | 10% | 229 |
5 | FLUOROURACIL | 98 | 11% | 38% | 857 |
6 | ORAL CAPECITABINE | 87 | 40% | 7% | 168 |
7 | FOLINIC ACID | 79 | 21% | 15% | 333 |
8 | 2 DIFFERENT SCHEDULES | 62 | 72% | 2% | 49 |
9 | FIRST LINE TREATMENT | 51 | 38% | 5% | 105 |
10 | IRINOTECAN | 50 | 15% | 14% | 312 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLINICAL COLORECTAL CANCER | 7 | 13% | 2% | 51 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer | 2015 | 3 | 61 | 39% |
Adjuvant therapy in colon cancer - what, when and how? | 2006 | 82 | 40 | 58% |
Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer A Systematic Review and Meta-analysis | 2011 | 84 | 28 | 43% |
Capecitabine: A review | 2005 | 209 | 60 | 45% |
Seeing the forest through the trees: A systematic review of the safety and efficacy of combination chemotherapies used in the treatment of metastatic colorectal cancer | 2014 | 5 | 75 | 44% |
Targeting thymidylate synthase in colorectal cancer: critical re-evaluation and emerging therapeutic role of raltitrexed | 2014 | 3 | 78 | 62% |
Targeted Agents and Oxaliplatin-containing Regimens for the Treatment of Colon Cancer | 2014 | 4 | 63 | 46% |
Management of advanced colorectal cancer: state of the art | 2006 | 57 | 34 | 59% |
Adjuvant therapy for completely resected stage II colon cancer | 2008 | 60 | 113 | 55% |
Adjuvant treatment of colorectal cancer | 2007 | 130 | 131 | 39% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GERCOR | 11 | 69% | 0.4% | 9 |
2 | SERV MALAD SANGUINES IMMUNITAI TUMORALES | 6 | 71% | 0.2% | 5 |
3 | MODULO ONCOL | 4 | 75% | 0.1% | 3 |
4 | GLOBAL MED AFFAIRS ONCOL | 3 | 50% | 0.2% | 4 |
5 | SURG ADJUVANT BREAST BOWEL PROJECT OPERAT | 3 | 60% | 0.1% | 3 |
6 | SERV MED INTERNE ONCOL | 3 | 18% | 0.6% | 14 |
7 | GASTROENTEROL ONCOL SERV | 2 | 67% | 0.1% | 2 |
8 | PDMP | 2 | 67% | 0.1% | 2 |
9 | UNITE GASTROENTEROL ONCOL DIGEST | 2 | 67% | 0.1% | 2 |
10 | KENT CANC | 2 | 50% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000234299 | BIOCHEMICAL MODULATION//LEUCOVORIN//FOLINIC ACID |
2 | 0.0000173959 | PANITUMUMAB//CETUXIMAB//METASTATIC COLORECTAL CANCER |
3 | 0.0000157297 | ORAL CHEMOTHERAPY//ORAL ANTICANCER AGENTS//ORAL ANTICANCER DRUGS |
4 | 0.0000139924 | DIHYDROPYRIMIDINE DEHYDROGENASE//DPYD//DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY |
5 | 0.0000120325 | ADVANCED GASTRIC CANCER//S 1//METASTATIC GASTRIC CANCER |
6 | 0.0000108084 | THYMIDYLATE SYNTHASE//DIHYDROPYRIMIDINE DEHYDROGENASE//OROTATE PHOSPHORIBOSYL TRANSFERASE |
7 | 0.0000098778 | TULAREMIA LIVE VACCINE//1 HEXYLCARBAMOYL 5 FLUOROURACIL//5 FLUOROURACIL AND 1 HEXYLCARBAMOYL 5 FLUOROURACIL |
8 | 0.0000096135 | COLORECTAL LIVER METASTASES//LIVER METASTASES//LIVER RESECTION |
9 | 0.0000095421 | GERIATRIC ONCOLOGY//JOURNAL OF GERIATRIC ONCOLOGY//SENIOR ADULT ONCOL PROGRAM |
10 | 0.0000081897 | OCCULT NEOPLASTIC CELLS//COMPLETE MESOCOLIC EXCISION//LYMPH NODE YIELD |